Assessing the effectiveness of empiric antimicrobial regimens in cases of septic/infected abortions.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
06 2020
Historique:
received: 02 05 2019
revised: 05 08 2019
accepted: 05 08 2019
pubmed: 25 8 2019
medline: 4 8 2020
entrez: 25 8 2019
Statut: ppublish

Résumé

Infected abortion is a life-threatening condition that requires immediate surgical and medical interventions. We aimed to assess the common pathogens associated with infected abortion and to test the microbial coverage of various empiric antimicrobial regimens based on the bacteriological susceptibility results in women with infected abortions. A retrospective study in a single university-affiliated tertiary hospital. Electronic records were searched for clinical course, microbial characteristics, and antibiotic susceptibility of all patients diagnosed with an infected abortion. The effectiveness of five antibiotic regimens was analyzed according to bacteriological susceptibility results. Overall, 84 patients were included in the study. The mean age of patients was 32.3(SD ± 5.8) years, and the median gestational age was 15 (IQR 8-19) weeks. Risk factors for infection were identified in 23 patients (27.3%), and included lack of medical insurance (n = 12), recent amniocentesis/chorionic villus sampling or fetal reduction due to multifetal pregnancies (n = 10). The most common pathogens isolated were Enterobacteriaceae (35%), Streptococci (31%), Staphylococci (9%) and Enterococci (9%). The combination of intravenous ampicillin, gentamicin and metronidazole showed significant superiority over all the other tested regimens according to the susceptibility test results. Piperacillin-tazobactam as an empiric single-agent drug of choice and provided a superior microbial coverage, with a coverage rate of 93.3%. A combination of ampicillin, gentamicin, and metronidazole had a better spectrum of coverage as a first-line empiric choice for patients with infected abortion.

Identifiants

pubmed: 31443937
pii: S0735-6757(19)30522-4
doi: 10.1016/j.ajem.2019.158389
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Gentamicins 0
Metronidazole 140QMO216E
Ampicillin 7C782967RD

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1123-1128

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors report no conflict of interest and that this research was non-funded.

Auteurs

Yuval Fouks (Y)

Lis Maternity Hospital, Department of Obstetrics and Gynecology, Tel Aviv Sourasky Medical Center (affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel. Electronic address: Fouksi@gmail.com.

Ofri Samueloff (O)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ishai Levin (I)

Lis Maternity Hospital, Department of Obstetrics and Gynecology, Tel Aviv Sourasky Medical Center (affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel.

Ariel Many (A)

Lis Maternity Hospital, Department of Obstetrics and Gynecology, Tel Aviv Sourasky Medical Center (affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel.

Sharon Amit (S)

The Department of Clinical Microbiology and Infectious Diseases, Hadassah University Hospital, Jerusalem, Israel.

Aviad Cohen (A)

Lis Maternity Hospital, Department of Obstetrics and Gynecology, Tel Aviv Sourasky Medical Center (affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH